Synthesis and antimalarial evaluation of some 4-quinazolinone derivatives based on febrifugine

Journal of Advanced Pharmaceutical Technology and Research

Volumn 1, Issue 4, 2010, Pages 401-405

  Sen, Debanjan ^a   Banerjee, Anirban ^b   Ghosh, Ashoke ^c   Chatterjee, Tapan ^d  

^a Bengal Institute of Pharmaceutical Sciences   (India)

^b Schrödinger LCC   (India)

^c IFTM   (India)

^d JADAVPUR UNIVERSITY   (India)

Author keywords

4 quinazolinone; Antimalarial activity; febrifugine; Plasmodium berghei

Indexed keywords

1 (OXIRAN 2 YLMETHYL)PIPERIDIN 4 ONE DERIVATIVE; 2 (3 BROMOPHENYL) 3 [2 HYDROXY 3 (4 OXOPERIDIN 1 YL)PROPYL]QUINAZOLIN 4(3H) ONE DERIVATIVE; 2 (4 BROMOPHENYL) 3 [2 HYDROXY 3 (4 OXOPERIDIN 1 YL)PROPYL]QUINAZOLIN 4(3H) ONE DERIVATIVE; 2 (4 CHLOROPHENYL) 3 [2 HYDROXY 3 (4 OXOPERIDIN 1 YL)PROPYL]QUINAZOLIN 4(3H) ONE DERIVATIVE; 2 (4 FLUOROPHENYL) 3 [2 HYDROXY 3 (4 OXOPERIDIN 1 YL)PROPYL]QUINAZOLIN 4(3H) ONE DERIVATIVE; 2,3 SUBSTITUTED QUINAZOLIN 4(3H) ONE DERIVATIVE; 3 [2 HYDROXY 3 (4 OXOPIPERIDIN 1 YL)PROPYL] 2 METHYLQUINAZOLIN 4(3H) ONE DERIVATIVE; 3 [2 HYDROXY 3 (4 OXOPIPERIDIN 1 YL)PROPYL] 2 PHENYLQUINAZOLIN 4(3H) ONE DERIVATIVE; 3 [2 HYDROXY 3 (4 OXOPIPERIDIN 1 YL)PROPYL] 2 TOLYLQUINAZOLIN 4(3H) ONE DERIVATIVE; 3 [2 HYDROXY 3 (4 OXOPIPERIDIN 1 YL)PROPYL]QUINAZOLIN 4(3H) ONE DERIVATIVE; 4(3H) QUINAZOLINONE DERIVATIVE; ARTEMISININ; CHLOROQUINE; FEBRIFUGINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SYNTHESIS; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SURVIVAL TIME; TREATMENT DURATION;

EID: 79952919190     PISSN: 22314040     EISSN: 09762094     Source Type: Journal    
DOI: 10.4103/0110-5558.76439     Document Type: Article

References (17)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7. (Pubitemid 40388051)
2. Bowman S, Lawson D, Basham D, Brown D, Chillingworth T, Churcher CM, et al. The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum. Nature 1999;400:532-8. (Pubitemid 29381795)
3. Gupta D, Yedidi RS, Varghese S, Kovari LC, Woster PM. Mechanism-based inhibitors of the aspartyl proteaase plasmepsin II as potential antimalarial agents. J Med Chem 2010;53:4234-47.
4. Kikuchi H, Tasaka H, Hirai S, Takaya Y, Iwabuchi Y, Ooi H, et al. Potent antimalarial febrifugine analogues against the plasmodium malaria parasite. J Med Chem 2002;45:2563-70. (Pubitemid 34595226)
5. Xie A, Sivaprakasam P, Doerksen RJ. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold. Bioorg Med Chem 2006;14:7311-23. (Pubitemid 44403103)
6. Koepfli JB, Mead JF, Brockman JA Jr. An alkaloid with high antimalarial activity from Dichroa febrifuga. J Am Chem Soc 1947;69:1837.
7. De Smet PA. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997;54:801-40. (Pubitemid 27526894)
8. Kikuchi H, Yamamoto K, Horoiwa S, Hirai S, Kasahara R, Hariguchi N, et al. Exploration of a new type of antimalarial compounds based on febrifugine. J Med Chem 2006;49:4698-706. (Pubitemid 44162697)
9. Kikuchi H, Yamamoto K, Horoiwa S, Hirai S, Kasahara R, Hariguchi N, et al. Exploration of a new type of antimalarial compounds based on febrifugine. J Med Chem 2006;49:4698-706. (Pubitemid 44162697)
10. Cruickshank PA. Febrifugine Antimalarial Agent. I Pyridine Analogs of febrifugine. Central research Department, New Jersey; 1970.
11. Zhu S, Meng L, Zhang Q, Wei L. Synthesis and evaluation of febrifugine analogues as potential antimalarial agents. Bioorg Med Chem Lett 2006;16:1854-8. (Pubitemid 43273263)
12. Jiang S, Zeng Q, Gettayacamin M, Tungtaeng A, Wannaying S, Lim A, et al. Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrob Agents Chemother 2005;49:1169-76. (Pubitemid 40327741)
13. Kang H, Wang GH. Benign and Efficient Synthesis of 2-Substituted 4 (3H) Quinazolinones Mediated by Iron (III) Chloride Hexahydrate in Refluxing Water. [Bull. Chem. Soc. Jpn.] 2006;79:1426-30. (Pubitemid 44681180)
14. Knight DJ, Peters W. The antimalarial activity of N- benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol 1980;74:393-404. (Pubitemid 11224160)
15. Peters W, Robinson BL, Tovey G, Rossier JC, Jefford CW. The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3: Observations on 'Fenozan-50F', a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane. Ann Trop Med Parasitol 1993;87:111-23. (Pubitemid 23196826)
16. Kimbi HK, Fagbenro-Beyioku AF, Oyibo WA. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice. Indian J Malariol 1998;35:35-8. (Pubitemid 29200085)
17. Weil CS. Tables for convenient calculation of median effective dose and instructions in their use. Biometrics 1952;8:247.